Related Experiment Video
Updated: Jun 10, 2026
12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
Expression of ADAMTS4 in Ewing's sarcoma
1Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan.
International Journal of Oncology
|July 29, 2010
Summary
Researchers identified ADAMTS4 as a potential tumor marker for Ewing sarcoma (EWS). This protein is highly expressed in EWS tumors, offering a new diagnostic possibility for this rare bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ewing sarcoma (EWS) is a rare bone cancer primarily affecting adolescents.
- The EWS-FLI1 fusion gene is the most common genetic driver of EWS.
- There is a need for reliable diagnostic markers for EWS.
Purpose of the Study:
- To identify novel biological markers for the diagnosis of Ewing sarcoma.
- To investigate the role of ADAMTS4 as a potential tumor marker in EWS.
Main Methods:
- Retrovirus-mediated signal sequence trap method for marker identification.
- Analysis of ADAMTS4 mRNA expression in EWS and other solid tumor samples.
- Immunohistochemistry to assess ADAMTS4 protein expression in EWS patient tumors.
Main Results:
- ADAMTS4 mRNA was detected in all examined EWS samples and cell lines.
- ADAMTS4 expression was significantly higher in EWS compared to other solid tumors.
- ADAMTS4 expression is regulated in an EWS-FLI1 fusion gene-dependent manner.
- High levels of ADAMTS4 protein were observed in EWS patient tumor samples.
Conclusions:
- ADAMTS4 is a novel and promising tumor marker for Ewing sarcoma.
- ADAMTS4 expression is linked to the EWS-FLI1 oncogenic pathway.
- Further validation of ADAMTS4 could improve EWS diagnosis and management.
